Insights Into Chronic Lymphocytic Leukemia (CLL) Northeast
Perspectives of community physicians from the northeast region of the United States on the management of newly diagnosed and relapsed/refractory chronic lymphocytic leukemia (CLL)
Faculty Chair
Javier Pinilla, MD, PhD
Moffitt Cancer Center, Tampa, FL, US
REPORT TOPICS INCLUDE
Report providing the insights from a moderated roundtable discussion focusing on treatment of CLL
Disease state and data presentations were developed in conjunction with Dr Javier Pinilla from Moffitt Cancer Center
Insights on the following CLL therapies were obtained:
- acalabrutinib, ibrutinib, zanubrutinib, obinutuzumab, rituximab, venetoclax, duvelisib, idelalisib, FCR, BR
Data collection was accomplished through use of audience response system questioning and in-depth moderated discussion
GEOGRAPHIC REPRESENTATION
The group of advisors comprised community oncologists from the northeast region of the United States
